Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Epiroc Q4 report and invitation to conference call on January 31

Stockholm, Sweden: Epiroc AB, a leading productivity partner for the mining and infrastructure industries, will publish its Q4 2019 results on Friday January 31, at approximately 7.30 CET. A combined presentation and conference call for investors, analysts and media will be held at 10.00 CET.The presentation will be held in Epiroc’s office, Sickla Industriväg 19, Nacka, Sweden. The report will be presented by President and CEO Per Lindberg and CFO Anders Lindén. The presentation will begin with a short presentation of the report followed by a question-and-answer session. The presentation

East Capital GEM fund is awarded LuxFLAG ESG certification

East Capital, the specialist emerging and frontier markets asset manager, is pleased to announce that its East Capital Global Emerging Markets Sustainable fund has been certified with the LuxFLAG ESG Label. The Luxembourg Finance Labelling Agency (LuxFLAG) is an independent and international non-profit association created in Luxembourg in July 2006 by seven public and private founding partners. The Luxembourg Government, ALFI, ABBL, ADA, the European Investment Bank, Luxembourg for Finance and the Luxembourg Stock Exchange are its Charter members. The primary objective of the LuxFLAG

Immunovia Strengthen Management with New Senior VP of Sales North America Ahead of the IMMray™ PanCan-d Test Launch

LUND, SWEDEN – Immunovia AB (publ) ) (“Immunovia”), a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced the build up of the Company’s management team with a new Senior Vice President of Sales NA (North America), Michael Pettigrew. “We are excited to welcome Michael Pettigrew to our team, as we continue to strengthen and prepare for our third quarter 2020 launch of IMMray™ PanCan-d, Immunovia’s test for early detection of pancreatic cancer,” said Mats Grahn, CEO of Immunovia. “Michael has a very

Indutrade acquires German supplier of automation solutions

Indutrade has on 10 January signed an agreement with the intent to acquire all of the shares in the German company STEIN Automation GmbH & Co. KG (www.stein-automation.de/wp/en/), with annual sales of approximately EUR 10 million. The agreement was signed after the market closed.Stein Automation is a supplier of Pallet transfer systems for assembly-lines. The systems are Industry 4.0-ready and built up by standardized modules, providing flexible configuration and re-modelling features, to optimize the customers’ production processes. The customers are companies primarily based in Germany,

Lynparza granted FDA Priority Review for PAOLA-1

13 January 2020 07:00 GMT   Lynparza regulatory submission granted Priority Review in the US for 1st-line maintenance treatment with bevacizumab in advanced ovarian cancer   Submission based on Phase III PAOLA-1 trial for patients with advancedovarian cancer regardless of biomarker status or surgical outcome   AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that a supplemental New Drug Application for Lynparza (olaparib) in combination with bevacizumab has been accepted and granted Priority Review

Siemens’ Parasolid introduces Convergent Modeling on mixed models

The latest version of Parasolid® software is now available from Siemens Digital Industries Software. The updates to Parasolid include enhancements to Convergent Modeling™ technology, which can now operate on models containing a mix of facet B-rep surfaces and classic B-rep surfaces, helping to enable more efficient work flows in a wide range of applications. For example, in generative design, where new products are autonomously developed to satisfy design constraints, Convergent Modeling can restore precise, classic mating surfaces to a model that has undergone facet-based topology

Stillfront Group AB: MAU grows 26% YoY

Stillfront Group AB (“Stillfront”) systematically works with improving the product portfolio to optimize performance and reward/risk. Among many things, Stillfront continuously monitors the number of active users of the online games on a monthly (MAU – Monthly Active User) and daily (DAU – Daily Active User) basis. During the fourth quarter of 2019, the average number of MAUs was 6,018,000 (compared to 4,770,000 in the corresponding period 2018). The number of DAUs was 1,394,000 on average during the quarter (compared to 1,140,000 in the corresponding period 2018). Thus, during the

DMC approves colorectal cancer cohort expansion

Faron Pharmaceuticals Oy ("Faron" or the "Company")   MATINS TRIAL UPDATE  Data monitoring committee approves initiation of expansion cohort in colorectal cancer patients     Company announcement, 13 January 2020 at 9.00 AM (EET)Inside information   TURKU - FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today announces approval from the MATINS trial's data monitoring committee ("DMC") to initiate the study's first expansion cohort, Part II, in patients suffering from late-stage colorectal cancer (

Proposals of the Shareholders’ Nomination Board to the Annual General Meeting

YIT Corporation                    Stock exchange release           January 13, 2020 at 9:00 a.m.Proposals of the Shareholders’ Nomination Board to the Annual General Meeting   The Shareholders’ Nomination Board of YIT Corporation presents the following proposals to the Annual General Meeting of YIT Corporation, which meets on March 12, 2020:   Number of members of the Board of Directors The Nomination Board proposes that a Chairman, a Vice Chairman and six (6) ordinary members be elected to the Board of Directors.   Fees of the Chairman, Vice Chairman and members of

Press release from Essity’s subsidiary Vinda

Essity’s subsidiary Vinda International Holdings Ltd today published a press release with the title ”Inside information and positive profit alert”. Link to the press release: http://www.vinda.com/upload/2020/0113/0816h8jv2p.pdfEssity is the majority shareholder of Vinda and owns 52% of the company. Vinda is listed on the Hong Kong Stock Exchange. Essity consolidates Vinda. For the first 9 months 2019 Vinda’s net sales accounted for approximately 15% of Essity’s net sales.

Update on Epanova Phase III STRENGTH trial

13 January 2020 07:00 GMT   Update on Phase III STRENGTH trial for Epanova in mixed dyslipidaemia   Independent Data Monitoring Committee has recommended to discontinuethe trial as Epanova is unlikely to demonstrate a benefit to patients   Following the recommendation from an independent Data Monitoring Committee, AstraZeneca has decided to close the Phase III STRENGTH trial for Epanova (omega-3 carboxylic acids) due to its low likelihood of demonstrating a benefit to patients with mixed dyslipidaemia (MDL) who are at increased risk of cardiovascular (CV) disease.

Australia’s first Waste to Energy plant to be powered by Konecranes’ refuse cranes

Konecranes will provide two refuse cranes to Avertas Energy, Australia’s first energy-from-waste facility in Kwinana, Western Australia . The order was booked in July 2019, with delivery planned for June 2020.Energy-from-waste uses post-recycling rubbish to generate clean, baseload power – the minimum amount of electric power needed for an electrical grid at any given time. The Kwinana facility will divert up to 400,000 tonnes of waste a year and generate an estimated 36 megawatts of electricity for the grid, enough to power

Nanoform appoints Head of US Sales

Helsinki, Finland – Nanoform, an innovative nanoparticle medicine enabling company, has appointed Sally Langa as Head of US Sales. The new role will enable Nanoform to continue its rapid growth with a strengthened presence in the US market. As Head of US Sales, Sally Langa will drive business development in this key region. Together with the rest of the commercial team, she will introduce and accelerate growth of Nanoform’s technology platform to major Pharma and Biotech companies in the US market. Sally Langa has more than 30 years of successful track record in senior business

Azelio signs MoU for energy storage project in Jordan

Azelio has agreed on a Memorandum of Understanding (MoU) with the Jordanian company Hussein Atieh & Sons Co. (HAE), to work together on setting up a small-scale project in Jordan. The project paves the way for a commercial collaboration of about 25 MWe of Azelio’s energy storage technology in the Jordanian market until 2023. This capacity is forecasted along the following timeline: 50 kWe in 2020, 3 MWe in 2021, 7 MW  in 2022 and 15 MWe in 2023.The first project will have a capacity of 50 kW with 13 hours of storage and will be installed in Jordan Q4 2020. The identified preliminary end-

CHANGES TO GLASTON’S GROUP STRUCTURE AND EXECUTIVE MANAGEMENT GROUP

Glaston Corporation                Stock Exchange Release 13 January 2020       8.30 am EETIn order to better reflect its business dynamics and market drivers, Glaston has made changes to the  Group structure. As of 1 January 2020, Glaston Corporation has three business areas: Glaston Heat Treatment Technologies, Glaston Insulating Glass Technologies and Glaston Automotive & Emerging Technologies. The business areas also form the company’s three reporting segments in which Services are included. Machine and Services sales, order intake and order book will also be reported separately as

Serneke’s Nomination Committee proposes that a new Chairman and two new Board members be elected

Ahead of the Annual General Meeting on May 5, 2020, the Nomination Committee of Serneke Group AB (publ) intends to nominate Jan C Johansson as the new Chairman of the Board, and Veronica Rörsgård and Per Åkerman as new Board members.Serneke Group’s Nomination Committee has decided to nominate Jan C Johansson as the new Chairman of the Board of Directors of Serneke Group AB. Jan is 65 years old and has held a wide range of senior positions within some of Sweden’s leading companies, including as Vice President of Vattenfall, Senior Vice President of Network Operations at Telia and as

Share buy-backs in Telia Company during week 2 2020

During the period January 6, 2020 until January 10, 2020, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,265,913 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back program that Telia Company announced on April 16, 2019. The share buy-back program, which runs between April 16, 2019 and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period January

Väderstad one of five finalists in The Royal Swedish Academy of Engineering Sciences competition, Smart industry

We are proud to have been named one of five finalists in The Royal Swedish Academy of Engineering Sciences competition, Smart industry. The competition rewards companies that make use of digitalisation opportunities in an innovative way with clear results. The winner will be appointed at a public seminar at The Royal Swedish Academy of Engineering Sciences in Stockholm on February 5[th].Väderstad’s machines and methods have been ground-breaking for generations and this is not the first time that Väderstad noticed for its innovative ability. - We are very proud and happy for the

Last patient included in Sedana Medical's pivotal IsoConDa study

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the last patient has now been included in the pivotal IsoConDa study. Thus, all 300 patients have been included and the study is expected to show top-line results during Q2 2020.“This is a true milestone for Sedana Medical. It is extremely gratifying that we keep the schedule in the world's largest study of inhaled sedation in intensive care. We expect to be able to present top-line results in the second quarter of 2020 and thus be able to submit our application for European market approval in 16 European countries in a

Africa Energy to Present at Investor Meeting in Stockholm

January 13, 2020 – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, announces that the Company’s President and Chief Executive Officer, Garrett Soden, will be presenting to shareholders and investors at a town hall meeting in Stockholm, Sweden on Monday, January 20, 2020, at 18:30 Central European Time (CET). The town hall meeting will be held at Näringslivets Hus on Storgatan 19 in Stockholm (local Industrisalen). Shareholders and investors are requested

Scandion Oncology to attend the JP Morgan 38th Annual Healthcare Conference

Scandion Oncology A/S (“Scandion Oncology”) Chief Executive Officer Nils Brünner and Chairman of the Board Peter Høngaard will be attending the JP Morgan 38th Annual Healthcare Conference 13-16 January 2020 in San Francisco.From January 13 to 16, 2020, Scandion Oncology will participate at the J.P. Morgan Healthcare Conference in San Francisco, USA. This annual conference, with more than 9,000 representatives from the pharmaceutical industry, the financial and service sectors and from academic institutions, is the largest of its kind in the world. CEO Nils Brünner says: According to our

Hansa Biopharma provides business update ahead of the JP Morgan Global Healthcare Conference

•    Responses to Day 120 questions submitted for EMA MAA of imlifidase•    First patients dosed in GBS trial; Enrollment in anti-GBM trial near completion•    Solid year-end cash positionLund, Sweden January 12, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced a business update for the fourth quarter 2019 and preliminary, unaudited key financials for its financial year 2019.  The company will be participating in the JP Morgan Global Healthcare Conference  in San Francisco from January 13 to 16, 2020. 2019

SBB controls approximately 91.2 percent of the shares in Hemfosa

Read more at www.sbb-hemfosa.se. For further information, please contact: Ilija Batljan, CEO and Founder of Samhällsbyggnadsbolaget i Norden AB, +46 70 518 39 67, ilija@sbbnorden.se This information is information that Samhällsbyggnadsbolaget i Norden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on January 10, 2020, at 21:30 CET. About Samhällsbyggnadsbolaget i Norden AB (publ) The company’s strategy is to own, manage and develop community

CURRENCY EXCHANGE RATES FOR THE FOURTH QUARTER 2019

Currency exchange rates for significant currencies in Betsson AB’s financial reports are found below. The exchange rates have no material impact on the Group’s operations, but affects the reported results when translated into the reporting currency SEK. Income statement average rates to SEK   January- December 2019  January-December 2018 YoY DeltaEUR 10.589 10.257 3.2%GBP 12.066 11.593 4.1%GEL 3.354 3.432 -2.3%NOK 1.075

There are no items matching the current filter
There are no more items matching the current filter
Back to top